Abstract # 1072 Phase I Study Of Stereotactic Radiotherapy For Unresectable Hepatocellular Carcinoma And Intrahepatic Cholangiocarcinoma

Presenter: Dawson, Laura

< Back to topics

> Cover Page, Authors, Institutions

> Purpose/Objective

> Materials/Methods

> Results/Discussion

> Conclusions

> View tables/images/videos

To report results of a phase I study of highly individualized, hypofractionated SRT in unresectable CC and HCC.

Patients with unresectable hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (CC) have few treatment options and a poor prognosis. Highly individualized, hypofractionated stereotactic radiotherapy (SRT) is a novel treatment with the potential to improve outcomes in HCC and CC.

Abstracts Main Page | Logout